
Prescription opioid use by one household member is associated with prescription opioid use in other household members.
Millions of opioid prescriptions are dispensed each year in the United States and unused opioids stored in household medicine cabinets are opportunities for drug sharing. However, whether is unknown.
Advertisement
‘Living in a household with a prescription opioid user may be associated with increased risk of prescription opioid use by other household members.’
Tweet it Now
Claims data for commercial insurance beneficiaries sharing a health plan from 2000 to 2014 were used to study the cause.
Outpatient pharmacy dispensing of a prescription opioid vs prescription NSAID (nonsteroidal anti-inflammatory drug) started by a household member (exposure); new dispensing by an outpatient pharmacy of a prescription opioid for another household member (outcome) was correlated.
Study Findings
The one-year risk of prescription opioid use was an absolute 0.71 percent higher among people in households where another person had an opioid prescription compared with households with an NSAID prescription. Living in a household with a prescription opioid user may increase the risk of prescription opioid use. Opioid prescribing decisions may need to consider the context within which the medications will be used and the potential risk of subsequent opioid initiation by other people in a household.
Source: Eurekalert
Advertisement
Study Findings
The one-year risk of prescription opioid use was an absolute 0.71 percent higher among people in households where another person had an opioid prescription compared with households with an NSAID prescription. Living in a household with a prescription opioid user may increase the risk of prescription opioid use. Opioid prescribing decisions may need to consider the context within which the medications will be used and the potential risk of subsequent opioid initiation by other people in a household.
Source: Eurekalert
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News

The impact of anti-obesity drugs on survival rates among osteoarthritis patients is under scrutiny, evaluating their potential influence on mortality risks.

Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.

Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.

The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.

The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.